NCCM
LXRX icon

Nine Chapters Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Nine Chapters Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,600
Closed -$134K – 1108
2015
Q2 		$134K Buy
16,600
+11,643
+235% +$85.5K 0.01% 848
2015
Q1 		$33K Sell
4,957
-1,214
-20% -$8.29K ﹤0.01% 935
2014
Q4 		$39K Buy
+6,171
New +$49.7K ﹤0.01% 897
2014
Q2 		– Sell
-2,843
Closed -$34K – 1044
2014
Q1 		$34K Buy
2,843
+300
+12% +$3.83K ﹤0.01% 785
2013
Q4 		$32K Buy
2,543
+572
+29% +$9.1K ﹤0.01% 767
2013
Q3 		$33K Buy
+1,971
New +$33.1K ﹤0.01% 722

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return